Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medro vs Pallas Health

By GLP-1 ScorecardUpdated

Our take

Start with Pallas’s four-week plan if you want a shorter commitment. Medro’s introductory offer requires three months paid upfront. Put the initial charge and the first regular renewal side by side before choosing.

Compare the same medication and supply period. Ask how much you could recover if you stop after a prescription is issued.

MedroFactor scores not reassessed.
Site position #271

Lower score

Pallas HealthFactor scores not reassessed.
Site position #142

Higher score

Score comparison

Pallas Health has the higher recorded score — 69.3/100 to 63.6/100.

Pallas Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pallas advertises four-week renewal or an annual option for compounded injections. Ask for the full amount due and confirm when a prescribed order becomes final.

Before you choose

Before comparing the headline prices, the Medro review and the Pallas Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Medro vs PauseRX and Options Medical Weight Loss vs Pallas Health compare each of them with another graded program, and the list of alternatives to Medro ranks the programs closest to Medro on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePallas Health +5
50
55
Dose & formulationMedro +1
77
76
Clinical oversightPallas Health +13
71
84
Labs & monitoringEven
52
52
FulfillmentMedro +6
92
86
Contract termsPallas Health +35
33
68
Medro · top barPallas Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMedroPallas Health
WeighScore63.6/10069.3/100
GradeCC
Site position#271#142
SemaglutideFrom $99/mo equivalent (introductory, quarterly prepay, compounded)$139 first period, then $199 every four weeks (compounded; confirm selected quote)
TirzepatideFrom $199/mo equivalent (introductory, quarterly prepay, compounded)$179 first period, then $299 every four weeks (compounded; confirm selected quote)
CoverageAll 50 statesConfirm treatment and visit requirements for your state
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedNot confirmed
Medro

Site position #271 · C

Factor scores not reassessed.

Strengths

  • Names its clinical group
  • Publishes a subscription cancellation deadline

What to consider

  • Advertised introductory rates require three months paid upfront
  • Ask for the regular renewal charge and the refund terms for your order
Pallas Health

Site position #142 · C

Factor scores not reassessed.

Strengths

  • Publishes first-period and four-week renewal amounts
  • Explains when the charge is triggered and how to cancel future renewal
  • Terms link to a pharmacy partner directory

What to consider

  • Annual monthly equivalents do not establish the selected debit
  • Once prescribed, the current cycle ordinarily is not prorated or refunded
  • The six-month promise has separate eligibility and timing requirements

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard